Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Natalie Wolfsdorff"'
Publikováno v:
Immunity, Inflammation and Disease, Vol 9, Iss 4, Pp 1702-1706 (2021)
Abstract Introduction One dose of a coronavirus disease 2019 (COVID‐19) vaccine can elicit high antibody titers in individuals who were previously infected by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). However, it is unclear
Externí odkaz:
https://doaj.org/article/5902431511f448c2b60cff0972da2504
Autor:
Doris Urlaub, Natalie Wolfsdorff, Jan‐Erik Hoffmann, Stefanie Dorok, Markus Hoffmann, Moritz Anft, Naomi Pieris, Patrick Günther, Bernhard Schaaf, Uwe Cassens, Peter Bröde, Maren Claus, Lea K. Picard, Sabine Wingert, Simone Backes, Deniz Durak, Nina Babel, Stefan Pöhlmann, Frank Renken, Stefan Raunser, Carsten Watzl
Publikováno v:
European journal of immunology, 52(5):810-815
Neutralizing antibodies against SARS-CoV-2 are important to protect against infection and/or disease. Using an assay to detect antibodies directed against the receptor binding domain (RBD) of SARS-CoV-2 Spike, we identified individuals with SARS-CoV-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a09bae60f6c3c05d38b532f2443191c
Wiley Online Library
Wiley Online Library
Publikováno v:
Immunity, Inflammation and Disease, 9(4):1702–1706
Immunity, Inflammation and Disease, Vol 9, Iss 4, Pp 1702-1706 (2021)
Immunity, Inflammation and Disease
Immunity, Inflammation and Disease, Vol 9, Iss 4, Pp 1702-1706 (2021)
Immunity, Inflammation and Disease
Introduction One dose of a coronavirus disease 2019 (COVID‐19) vaccine can elicit high antibody titers in individuals who were previously infected by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). However, it is unclear how a SAR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f322378da611783d315f6b9170899ef5
Wiley Online Library
Wiley Online Library